US-based Bionik Laboratories Corp. has entered into a distribution agreement with Pro-Med Technology, a provider of medical equipment based in Hong Kong. The agreement between the two companies will grant Pro-Med Technology with the exclusive rights to market and sell Bionik’s InMotion Arm/Hand robotic device in Hong Kong.

Bionik’s InMotion robots are used in rehabilitation following stroke and other neurological conditions to help patients regain arm and hand movement. The robot guides patients through specific tasks, aiming to improve motor control of the arm and hand by increasing strength, range of motion and coordination, and assisting with the provision of efficient, effective, intensive sensorimotor therapy.

InMotion robots assist patients as needed while measuring the position, speed and acceleration to adjust to the patient’s needs during each session. Extensive clinical data on more than 1,000 patients has demonstrated that the InMotion robots provide more effective patient outcomes than traditional therapy alone.

Bionik InMotion devices are now present across 20 countries worldwide. This recent distribution agreement follows the company’s continued efforts to expand InMotion’s presence in Hong Kong, as well as other new markets including the EU, Canada, and Brazil.